Eversept Partners’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Eversept Partners’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-445,059	Closed	-$8.3M	–	105
2022 Q1	$8.3M	Sell	445,059 -441,081	-50%	-$7.94M	0.64%	41
2021 Q4	$19M	Sell	886,140 -28,846	-3%	-$568K	1.21%	22
2021 Q3	$16.9M	Sell	914,986 -479,298	-34%	-$9.65M	1.17%	23
2021 Q2	$29.9M	Buy	1,394,284 +19,056	+1%	+$387K	1.99%	20
2021 Q1	$26.5M	Buy	+1,375,228	New	+$24.2M	1.99%	19

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eversept Partners's OCDX Position: Q2 2022 in Review

Eversept Partners sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 445,059 shares — an estimated $8.3M sold.

Eversept Partners first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $29.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Eversept Partners reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Eversept Partners sold 445,059 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $8.3M.
Eversept Partners first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Eversept Partners's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $29.9M in Q2 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.